Comparison of LTA in Patients with Bleeding Disorder of Unknown Cause and Healthy Blood Donors – Now on RPTH Journal
RPTH Journal shared a post on LinkedIn:
“A new study reassesses guideline-recommended agonist concentrations for light transmission aggregometry (LTA). By comparing individuals with bleeding disorder of unknown cause to healthy donors, the work from Lena-Theresa Fanenbruck highlights important considerations for interpreting LTA results in clinical practice.
Read the full article in RPTH for the full analysis and implications for testing standards.”
Ttile: Comparison of light transmission aggregometry in patients with bleeding disorder of unknown cause and healthy blood donors
Authors: Lena-Theresa Fanenbruck, Michael Metze, Maria Weise, Martin Federbusch, Roland Siegemund, Martin Reinhard Henschler, Annelie Siegemund, Sirak Petros, Christian Pfrepper
Get the latest insights on Hemostasis Today.
-
Sep 30, 2026, 15:58Bernhard Merget: New Frontiers in Thrombosis and Stroke Research
-
Sep 30, 2026, 15:39Ifeanyichukwu Ifechidere: The Molecular Orchestra of Primary Hemostasis
-
Sep 30, 2026, 15:28Reassessing the Benefit–Risk Balance of Extended Anticoagulation in Cancer Patients – ESC Working Group on Cardiovascular Pharmacotherapy
-
Sep 30, 2026, 15:07Chiranjeev Sharma: Targeting Factor XIa with the Synthetic Inhibitor SB-01
-
Sep 30, 2026, 14:41Bruna Gigante: Balancing Thrombosis and Bleeding in Cardiovascular Care
-
Sep 30, 2026, 14:13Ashok Choudhury: Portal Vein Thrombosis and Outcomes in Cirrhosis
-
Sep 30, 2026, 13:57Leslye Conde Bazán: When Conventional Imaging Is Not Enough – The Role of IVUS
-
Sep 30, 2026, 13:41Huda Salah Eldin: The Challenge of Balancing Antithrombotic Therapy After PCI
-
Sep 30, 2026, 13:29Abdus Salam: What Can CT Venography Reveal About the Veins?